Safety and Tolerability of mRNA COVID-19 Vaccines in Kidney Transplant Recipients

BACKGROUND: COVID-19 mRNA vaccines have demonstrated excellent short-term safety in phase 3 trials. However, no kidney transplant recipients (KTR) were included. The aim of the study was to assess the safety and tolerability of COVID-19 mRNA vaccines in KTR. MATERIALS AND METHODS: A longitudinal con...

Descripción completa

Detalles Bibliográficos
Autores principales: Ślizień, Zuzanna, Muchlado, Marta, Kubanek, Alicja, Biedunkiewicz, Bogdan, Renke, Marcin, Komorowska, Karolina, Dębska-Ślizień, Alicja, Tylicki, Leszek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8926897/
https://www.ncbi.nlm.nih.gov/pubmed/35961734
http://dx.doi.org/10.1016/j.transproceed.2022.02.025

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8926897/
https://www.ncbi.nlm.nih.gov/pubmed/35961734
http://dx.doi.org/10.1016/j.transproceed.2022.02.025

Ejemplares similares